Evidence map›Paper›PMID 35763168›Full record

ArticleJournal of thrombosis and thrombolysis2022

Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection.

Eileen Shiuan, Deva Sharma, E Wesley Ely, Nikil Moodabagil, Benjamin F Tillman

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Eileen ShiuanMedical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, TN, USA.
Deva SharmaDepartment of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
E Wesley ElyDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Nikil MoodabagilDepartment of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Benjamin F TillmanDepartment of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. Benjamin.f.tillman@vumc.org.ORCID http://orcid.org/0000-0001-6282-9322
Vanderbilt University Medical Center · USAllen Institute for Brain Science · USVanderbilt University · USVA Tennessee Valley Healthcare System · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
NIGMS NIH HHS T32 GM007347NIH HHS T32 GM007347
6 · The paper itself

Abstract

Heparin-induced thrombocytopenia (HIT) occurs with the development of IgG antibodies that bind complexes of heparin and platelet factor 4 (PF4), which activate platelets and result in a profoundly prothrombotic condition. In rare instances, this syndrome develops in the absence of proximate heparin administration, referred to as spontaneous HIT, for which less than three dozen cases have been reported. Spontaneous HIT is considered a subtype of "autoimmune HIT" (aHIT), characterized by platelet activation in the serotonin release assay (SRA) without the addition of exogenous heparin. Here, we report spontaneous HIT as the presenting feature in a patient with 2019 coronavirus disease infection (COVID-19).A 66-year-old male presented with progressive leg pain and was found to have a platelet count of 39 × 10

Indexed as

COVID-19ThrombocytopeniaAgedAnticoagulantsHeparinHumansImmunoglobulin GImmunologic FactorsIschemiaMalePlatelet Factor 4AnticoagulantsHeparinImmunoglobulin GImmunologic FactorsPlatelet Factor 4COVID-19HeparinImmunoglobulins, IntravenousThrombocytopeniaThrombosis

Identifiers

PMID35763168
PMCPMC9243831
OpenAlexW4283650992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.